Equity

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Astrazeneca Pharma India LtdIndustry : Pharmaceuticals - Multinational
BSE Code:506820 NSE Symbol: ASTRAZEN P/E (TTM) :83.72
ISIN Demat:INE203A01020 Div & Yield %:0.3 EPS (TTM) :63.8
Book Value (RS) :261.98604 Market Cap (Rs Cr.):13353.13 Face Value (RS) :2
    Change Company 
Particulars Quarter Ended
(Dec 2023)
Quarter Ended
(Dec 2022)
Quarter Ended
(% Var)
Sales 305.79 249.81 22.41
Other Income 9.66 7.20 34.17
PBIDT 24.72 43.79 -43.55
Interest 0.61 0.20 205.00
PBDT 24.10 43.59 -44.71
Depreciation 3.70 4.13 -10.41
PBT 20.40 39.46 -48.30
Tax 4.65 9.85 -52.79
Deferred Tax -0.06 0.31 -119.35
PAT 15.80 29.30 -46.08

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)